Board Member*
- Biotechnology finance and banking.
- Broadmark Capital
- ARCH Venture Partners
- Co-founding Managing Director of RiverVest Venture Partners
- Venture investor in Conforma Therapeutics, Xcyte Therapies, and CGI Pharmaceuticals
- PhD (Bioengineering) from Univeristy of Pennsylvania
*Board tenure to start in Q1 of 2019; advisory to Board in interim term.
